This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Teichopsia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Teichopsia

  • visual aura in migraine that is described as
    • the fortification spectra, or teichopsia
      • this phenomenon -so characteristic that it may be considered almost as pathognomonic of migraine
        • is characterized by a series of complex interlacing angulated black-and-white (less frequently colorful) flickering and scintillating lines and bars that start as a small greyish spot in the visual field, more often paracentrally, less frequently at the center, growing over time from near the center towards the periphery, leaving a scotoma behind (1)
        • also known as "fortification spectra" because of its resemblance to the fortifications of a castle or fort seen from above

      • term, Greek for "town-wall vision" based on a series of descriptions of the positive phenomena of aura being angular, like those of fortifications, dating back to a 1778 paper by the physician John Fothergill (2)

Contributor:

Dr Mukesh Mistry, GP with Specialist Interest in Diabetes and Lipids (March 14th 2023)

Reference:

  • Hadjikhani N, Vincent M. Visual Perception in Migraine: A Narrative Review. Vision (Basel). 2021 Apr 28;5(2):20.
  • Weatherall MW. From "Transient Hemiopsia" to Migraine Aura. Vision (Basel). 2021 Nov 5;5(4):54. doi: 10.3390/vision5040054.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.